Sabrina Pengam

Title: Sabrina Pengam: Innovator in Immunotherapy

Introduction

Sabrina Pengam is a notable inventor based in Saint-Luce-sur-Loire, France. She has made significant contributions to the field of immunotherapy, particularly through her innovative work on humanized anti-CLEC-1A antibodies. Her research focuses on developing specific antibodies that can effectively target the CLEC-1A receptor, which plays a crucial role in various immune responses.

Latest Patents

Sabrina holds 1 patent for her invention titled "Humanized anti-CLEC-1A antibodies and antigen-binding fragments thereof." This invention provides specific humanized antibodies and their fragments that can bind to the CLEC-1A receptor. The compounds developed through her research are designed to antagonize the binding of CLEC-1A to its endogenous ligands, offering potential therapeutic applications for treating deleterious conditions.

Career Highlights

Throughout her career, Sabrina has worked with esteemed institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de Nantes. Her work in these organizations has allowed her to advance her research and collaborate with other experts in the field of immunotherapy.

Collaborations

Sabrina has collaborated with Caroline Mary, a fellow researcher, to further enhance the impact of her work in immunotherapy. Their partnership has contributed to the development of innovative solutions in the medical field.

Conclusion

Sabrina Pengam's contributions to immunotherapy through her patented inventions highlight her role as a leading innovator in the field. Her work continues to pave the way for advancements in medical treatments, showcasing the importance of research and collaboration in addressing health challenges.